Ilaria Cuccu

ORCID: 0000-0002-3711-5309
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Gynecological conditions and treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Genetic factors in colorectal cancer
  • PARP inhibition in cancer therapy
  • Sarcoma Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects
  • Surgical Simulation and Training
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Genomics and Diagnostics
  • Vascular Tumors and Angiosarcomas
  • MicroRNA in disease regulation
  • Prenatal Screening and Diagnostics
  • Reproductive Biology and Fertility
  • Surgical site infection prevention
  • Breast Cancer Treatment Studies
  • MRI in cancer diagnosis
  • Reproductive System and Pregnancy
  • Frailty in Older Adults

Sapienza University of Rome
2022-2025

Policlinico Umberto I
2022-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2024

Fondazione IRCCS Istituto Nazionale dei Tumori
2024

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
2023

The objective of this work is to assess the 5-year outcomes patients undergoing conization for high-grade cervical lesions that simultaneously present as risk factors in persistence HPV infection and positivity surgical resection margins. This a retrospective study evaluating lesions. All included had both positive margins experienced at 6 months. Associations were evaluated with Cox proportional hazard regression summarized using ratio (HR). charts 2966 reviewed. Among whole population, 163...

10.3390/vaccines11030698 article EN cc-by Vaccines 2023-03-18
Giorgio Bogani Violante Di Donato Giovanni Scambia Fabio Landoni Fabio Ghezzi and 95 more Ludovico Muzii Pierluigi Benedetti Panici Francesco Raspagliesi Giorgio Bogani Violante Di Donato Giovanni Scambia Fabio Ghezzi Jvan Casarin Fabio Landoni Giampaolo Di Martino Tommaso Grassi Anna Myriam Perrone Pierandrea De Iaco Francesco Multinu Roberto Berretta Vito Andrea Capozzi Errico Zupi Gabriele Centini Antonio Pellegrino Silvia Corso Stefania Stevenazzi Anna Chiara Boschi Giuseppe Comerci Pantaleo Greco Gennaro Scutiero Francesco Sopracordevole Giorgio Giorda Mariasole Fichera Tommaso Simoncini Marta Caretto Enrico Sartori Federico Ferrari Antonio Cianci Giuseppe Sarpietro Maria Grazia Matarazzo Pierluigi Giampaolino Giuseppe Bifulco Michele Morelli Michele Di Dio Annamaria Ferrero Nicoletta Biglia Fabio Barra Simone Ferrero Stefano Cianci Vito Chiàntera Gabriella Sozzi Alfredo Ercoli Sergio Schettini Teresa Orlando Francesco Cannone Giuseppe Ettore Andrea Puppo Elena Olearo Umberto Leone Roberti Maggiore Valeria Artuso Innocenza Palaia Giorgia Perniola Rossana Tripodi Tullio Golia D’Augè Ilaria Cuccu Margherita Fischetti Giusi Santangelo Assunta Casorelli Andrea Giannini Ottavia D’Oria Giuseppe Vizzielli Stefano Restaino Alice Bergamini Luca Bocciolone Francesco Plotti Roberto Angioli Giulia Mantovani Marcello Ceccaroni C. Cassini Mattia Dominoni Laura Giambanco Silvia Amodeo Livio Leo Raphaël Thommaset Diego Raimondo Renato Seracchioli Mario Malzoni Francesca Falcone Franco Gorlero Martina Di Luca Enrico Busato Sami Kilzie A Dell’Acqua Giovanna Scarfone Paolo Vercellini Marco Petrillo Giampiero Capobianco Andrea Ciavattini Liliana Mereu Paolo Scollo

10.1016/j.ygyno.2022.07.022 article EN Gynecologic Oncology 2022-07-29

Introduction Cervical cancer is the fourth most common cause of cancer-related death worldwide. High-risk locally advanced or recurrent/metastatic cervical cancers have a poor prognosis with routine treatments. The objective this study to analyze data available in literature on therapies and molecules currently use improve recurrent cancer.

10.1080/14656566.2023.2298329 article EN Expert Opinion on Pharmacotherapy 2023-12-30

10.1016/j.ejso.2024.108467 article EN European Journal of Surgical Oncology 2024-06-12

High- and low-risk endometrial carcinoma (EC) differ in whether or not a lymphadenectomy is performed. We aimed to develop MRI-based radio-genomic models able preoperatively assess lymph-vascular space invasion (LVSI) discriminate between low- high-risk EC according the ESMO-ESGO-ESTRO 2020 guidelines, which include molecular risk classification proposed by “ProMisE”. This retrospective, multicentric study that included 64 women with who underwent 3T-MRI before hysterectomy. Radiomics...

10.3390/cancers14235881 article EN Cancers 2022-11-29

Objective To assess if the use of a V-Y reconstructive flap after excisional radical surgery positively influences surgical outcomes in patients with vulvar cancer. Methods This was multicenter, retrospective, controlled study. Surgical and complication rates women invasive cancer who underwent reconstruction those without step were compared. Only bilateral or unilateral advancement fascio-cutaneous flaps included group. Univariate multivariate logistic regression models used to analyze...

10.1136/ijgc-2024-005486 article EN International Journal of Gynecological Cancer 2024-07-13

Background/Objectives: The optimal treatment for locally advanced cervical cancer (LACC) is debated. proposed treatments are concomitant chemoradiotherapy plus brachytherapy (cCTRT-B) or neoadjuvant chemotherapy (NACT) followed by radical surgery (RS). prediction NACT response crucial identifying responder patients who may benefit from subsequent surgery. aim of this study was to find ultrasound characteristics predict the in with LACC. Methods: Consecutive diagnoses LACC were prospectively...

10.3390/diagnostics15040463 article EN cc-by Diagnostics 2025-02-14
Coming Soon ...